Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

All NewsApril 21, 2026

Danaher Q1 earnings beat estimates as bioprocessing drives growth, while diagnostics weakens, and the respiratory outlook is lowered.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent